HEADER TRANSFERASE/TRANSFERASE INHIBITOR 08-SEP-17 6AYW TITLE THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: CALCIUM/CALMODULIN-DEPENDENT PROTEIN KINASE TYPE II SUBUNIT COMPND 3 DELTA; COMPND 4 CHAIN: A, B; COMPND 5 FRAGMENT: UNP RESIDUES 3-301; COMPND 6 SYNONYM: CAMK-II SUBUNIT DELTA; COMPND 7 EC: 2.7.11.17; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: CAMK2D, CAMKD; SOURCE 6 EXPRESSION_SYSTEM: UNIDENTIFIED BACULOVIRUS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 10469 KEYWDS KINASE, CAMKII, INHIBITOR, TRANSFERASE, TRANSFERASE-TRANSFERASE KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.R.SOMOZA,A.G.VILLASENOR REVDAT 2 13-MAR-24 6AYW 1 REMARK REVDAT 1 15-NOV-17 6AYW 0 JRNL AUTH J.R.SOMOZA,A.G.VILLASENOR JRNL TITL THE STRUCTURE OF HUMAN CAMKII WITH BOUND INHIBITOR JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.05 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.12_2829) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.05 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.23 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.337 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 3 NUMBER OF REFLECTIONS : 36326 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.202 REMARK 3 R VALUE (WORKING SET) : 0.199 REMARK 3 FREE R VALUE : 0.267 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.520 REMARK 3 FREE R VALUE TEST SET COUNT : 2008 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.2400 - 4.9400 0.92 2467 139 0.1669 0.2242 REMARK 3 2 4.9400 - 3.9200 0.92 2425 146 0.1546 0.2223 REMARK 3 3 3.9200 - 3.4300 0.95 2482 139 0.1788 0.2348 REMARK 3 4 3.4300 - 3.1100 0.97 2515 150 0.2057 0.2576 REMARK 3 5 3.1100 - 2.8900 0.98 2598 147 0.2170 0.3098 REMARK 3 6 2.8900 - 2.7200 0.99 2556 156 0.2226 0.2815 REMARK 3 7 2.7200 - 2.5800 0.99 2595 147 0.2257 0.2896 REMARK 3 8 2.5800 - 2.4700 0.99 2576 154 0.2272 0.3312 REMARK 3 9 2.4700 - 2.3800 0.99 2579 150 0.2316 0.2917 REMARK 3 10 2.3800 - 2.2900 0.99 2574 155 0.2263 0.3295 REMARK 3 11 2.2900 - 2.2200 0.98 2546 141 0.2408 0.3085 REMARK 3 12 2.2200 - 2.1600 0.94 2463 139 0.2458 0.2883 REMARK 3 13 2.1600 - 2.1000 0.87 2255 139 0.2572 0.3513 REMARK 3 14 2.1000 - 2.0500 0.65 1687 106 0.2874 0.3917 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.271 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 31.910 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 38.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 4902 REMARK 3 ANGLE : 0.868 6629 REMARK 3 CHIRALITY : 0.051 707 REMARK 3 PLANARITY : 0.006 850 REMARK 3 DIHEDRAL : 12.310 2947 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6AYW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-SEP-17. REMARK 100 THE DEPOSITION ID IS D_1000229999. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 06-DEC-12 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36488 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.050 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.9 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: EPMR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.14 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CAMKII S3-K301, IN 20MM IMIDAZOLE PH REMARK 280 8.5, 0.3M SODIUM CHLORIDE, 5MM TCEP, WAS CONCENTRATED TO 36 MG/ REMARK 280 ML AND FLASH FROZEN IN LIQUID NITROGEN FOR LONG TERM STORAGE AT - REMARK 280 80 C IN 10 MICROL ALIQUOTS. THE PROTEIN WAS THAWED AND DILUTED REMARK 280 DOWN TO 12 MG/ML IN THE SAME BUFFER JUST PRIOR TO REMARK 280 CRYSTALLIZATION EXPERIMENTS. SITTING DROP VAPOR DIFFUSION REMARK 280 DROPLETS WERE ASSEMBLED WITH 250 NL OF 12 MG/ML CAMKII, 0.6 MM REMARK 280 INHIBITOR AND 250 NL OF RESERVOIR SOLUTION 24% PEG 3350, 0.2 M REMARK 280 AMMONIUM TARTRATE, 0.1 M ARGININE. FLAT CRYSTAL PLATES REMARK 280 (TYPICALLY 0.03 MM X 0.2 MM X 0.4 MM IN SIZE) GREW IN 4-7 DAYS REMARK 280 AT 20 C. A CRYSTAL SEED SUSPENSION WAS PREPARED WITH TEN CRUSHED REMARK 280 CRYSTALS COMBINED INTO 100 UL OF RESERVOIR SOLUTION AND STORED REMARK 280 AT -80 C. A THIRTY FOLD SEED DILUTION WAS PREPARED IN THE SAME REMARK 280 SOLUTION FOR ADDITION TO PROTEIN DROPLETS IN A 1 TO 1 VOLUME REMARK 280 RATIO TO ENHANCE CRYSTALLIZATION OF DIFFICULT TO CRYSTALLIZE REMARK 280 INHIBITORS., VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.05500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 HIS A 1 REMARK 465 MET A 2 REMARK 465 SER A 3 REMARK 465 THR A 4 REMARK 465 THR A 5 REMARK 465 THR A 6 REMARK 465 CYS A 7 REMARK 465 LYS A 301 REMARK 465 GLY B 0 REMARK 465 HIS B 1 REMARK 465 MET B 2 REMARK 465 SER B 3 REMARK 465 THR B 4 REMARK 465 THR B 5 REMARK 465 THR B 6 REMARK 465 LEU B 300 REMARK 465 LYS B 301 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 NE2 GLN B 169 O HOH B 501 1.67 REMARK 500 OE1 GLU B 97 O HOH B 502 2.10 REMARK 500 OE2 GLU A 122 O HOH A 501 2.11 REMARK 500 OG SER B 235 OD2 ASP B 239 2.12 REMARK 500 O HOH A 538 O HOH A 625 2.13 REMARK 500 N THR A 8 O HOH A 502 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 505 O HOH B 551 2556 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 17 -143.22 -119.72 REMARK 500 ARG A 135 -3.66 76.44 REMARK 500 ASP A 136 50.45 -147.56 REMARK 500 ASP A 157 94.93 66.98 REMARK 500 PHE A 172 32.75 -86.93 REMARK 500 PHE A 233 70.48 -119.79 REMARK 500 LEU A 253 41.17 -101.49 REMARK 500 PHE B 17 -141.30 -115.25 REMARK 500 GLU B 18 159.30 -47.95 REMARK 500 ARG B 135 -6.98 76.86 REMARK 500 ASP B 157 89.59 60.28 REMARK 500 LEU B 253 45.67 -91.81 REMARK 500 ARG B 284 79.46 -114.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue C2V A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DTT A 402 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DTT B 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue C2V B 402 DBREF 6AYW A 3 301 UNP Q13557 KCC2D_HUMAN 3 301 DBREF 6AYW B 3 301 UNP Q13557 KCC2D_HUMAN 3 301 SEQADV 6AYW GLY A 0 UNP Q13557 EXPRESSION TAG SEQADV 6AYW HIS A 1 UNP Q13557 EXPRESSION TAG SEQADV 6AYW MET A 2 UNP Q13557 EXPRESSION TAG SEQADV 6AYW GLY B 0 UNP Q13557 EXPRESSION TAG SEQADV 6AYW HIS B 1 UNP Q13557 EXPRESSION TAG SEQADV 6AYW MET B 2 UNP Q13557 EXPRESSION TAG SEQRES 1 A 302 GLY HIS MET SER THR THR THR CYS THR ARG PHE THR ASP SEQRES 2 A 302 GLU TYR GLN LEU PHE GLU GLU LEU GLY LYS GLY ALA PHE SEQRES 3 A 302 SER VAL VAL ARG ARG CYS MET LYS ILE PRO THR GLY GLN SEQRES 4 A 302 GLU TYR ALA ALA LYS ILE ILE ASN THR LYS LYS LEU SER SEQRES 5 A 302 ALA ARG ASP HIS GLN LYS LEU GLU ARG GLU ALA ARG ILE SEQRES 6 A 302 CYS ARG LEU LEU LYS HIS PRO ASN ILE VAL ARG LEU HIS SEQRES 7 A 302 ASP SER ILE SER GLU GLU GLY PHE HIS TYR LEU VAL PHE SEQRES 8 A 302 ASP LEU VAL THR GLY GLY GLU LEU PHE GLU ASP ILE VAL SEQRES 9 A 302 ALA ARG GLU TYR TYR SER GLU ALA ASP ALA SER HIS CYS SEQRES 10 A 302 ILE GLN GLN ILE LEU GLU SER VAL ASN HIS CYS HIS LEU SEQRES 11 A 302 ASN GLY ILE VAL HIS ARG ASP LEU LYS PRO GLU ASN LEU SEQRES 12 A 302 LEU LEU ALA SER LYS SER LYS GLY ALA ALA VAL LYS LEU SEQRES 13 A 302 ALA ASP PHE GLY LEU ALA ILE GLU VAL GLN GLY ASP GLN SEQRES 14 A 302 GLN ALA TRP PHE GLY PHE ALA GLY THR PRO GLY TYR LEU SEQRES 15 A 302 SER PRO GLU VAL LEU ARG LYS ASP PRO TYR GLY LYS PRO SEQRES 16 A 302 VAL ASP MET TRP ALA CYS GLY VAL ILE LEU TYR ILE LEU SEQRES 17 A 302 LEU VAL GLY TYR PRO PRO PHE TRP ASP GLU ASP GLN HIS SEQRES 18 A 302 ARG LEU TYR GLN GLN ILE LYS ALA GLY ALA TYR ASP PHE SEQRES 19 A 302 PRO SER PRO GLU TRP ASP THR VAL THR PRO GLU ALA LYS SEQRES 20 A 302 ASP LEU ILE ASN LYS MET LEU THR ILE ASN PRO ALA LYS SEQRES 21 A 302 ARG ILE THR ALA SER GLU ALA LEU LYS HIS PRO TRP ILE SEQRES 22 A 302 CYS GLN ARG SER THR VAL ALA SER MET MET HIS ARG GLN SEQRES 23 A 302 GLU THR VAL ASP CYS LEU LYS LYS PHE ASN ALA ARG ARG SEQRES 24 A 302 LYS LEU LYS SEQRES 1 B 302 GLY HIS MET SER THR THR THR CYS THR ARG PHE THR ASP SEQRES 2 B 302 GLU TYR GLN LEU PHE GLU GLU LEU GLY LYS GLY ALA PHE SEQRES 3 B 302 SER VAL VAL ARG ARG CYS MET LYS ILE PRO THR GLY GLN SEQRES 4 B 302 GLU TYR ALA ALA LYS ILE ILE ASN THR LYS LYS LEU SER SEQRES 5 B 302 ALA ARG ASP HIS GLN LYS LEU GLU ARG GLU ALA ARG ILE SEQRES 6 B 302 CYS ARG LEU LEU LYS HIS PRO ASN ILE VAL ARG LEU HIS SEQRES 7 B 302 ASP SER ILE SER GLU GLU GLY PHE HIS TYR LEU VAL PHE SEQRES 8 B 302 ASP LEU VAL THR GLY GLY GLU LEU PHE GLU ASP ILE VAL SEQRES 9 B 302 ALA ARG GLU TYR TYR SER GLU ALA ASP ALA SER HIS CYS SEQRES 10 B 302 ILE GLN GLN ILE LEU GLU SER VAL ASN HIS CYS HIS LEU SEQRES 11 B 302 ASN GLY ILE VAL HIS ARG ASP LEU LYS PRO GLU ASN LEU SEQRES 12 B 302 LEU LEU ALA SER LYS SER LYS GLY ALA ALA VAL LYS LEU SEQRES 13 B 302 ALA ASP PHE GLY LEU ALA ILE GLU VAL GLN GLY ASP GLN SEQRES 14 B 302 GLN ALA TRP PHE GLY PHE ALA GLY THR PRO GLY TYR LEU SEQRES 15 B 302 SER PRO GLU VAL LEU ARG LYS ASP PRO TYR GLY LYS PRO SEQRES 16 B 302 VAL ASP MET TRP ALA CYS GLY VAL ILE LEU TYR ILE LEU SEQRES 17 B 302 LEU VAL GLY TYR PRO PRO PHE TRP ASP GLU ASP GLN HIS SEQRES 18 B 302 ARG LEU TYR GLN GLN ILE LYS ALA GLY ALA TYR ASP PHE SEQRES 19 B 302 PRO SER PRO GLU TRP ASP THR VAL THR PRO GLU ALA LYS SEQRES 20 B 302 ASP LEU ILE ASN LYS MET LEU THR ILE ASN PRO ALA LYS SEQRES 21 B 302 ARG ILE THR ALA SER GLU ALA LEU LYS HIS PRO TRP ILE SEQRES 22 B 302 CYS GLN ARG SER THR VAL ALA SER MET MET HIS ARG GLN SEQRES 23 B 302 GLU THR VAL ASP CYS LEU LYS LYS PHE ASN ALA ARG ARG SEQRES 24 B 302 LYS LEU LYS HET C2V A 401 28 HET DTT A 402 8 HET DTT B 401 8 HET C2V B 402 28 HETNAM C2V N-[2-(DIMETHYLAMINO)ETHYL]-3-[6-(THIOPHEN-2-YL) HETNAM 2 C2V IMIDAZO[1,2-B]PYRIDAZIN-3-YL]BENZAMIDE HETNAM DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE HETSYN DTT 1,4-DITHIOTHREITOL FORMUL 3 C2V 2(C21 H21 N5 O S) FORMUL 4 DTT 2(C4 H10 O2 S2) FORMUL 7 HOH *259(H2 O) HELIX 1 AA1 THR A 8 GLU A 13 1 6 HELIX 2 AA2 SER A 51 LEU A 68 1 18 HELIX 3 AA3 GLU A 97 VAL A 103 1 7 HELIX 4 AA4 SER A 109 ASN A 130 1 22 HELIX 5 AA5 LYS A 138 GLU A 140 5 3 HELIX 6 AA6 SER A 146 GLY A 150 5 5 HELIX 7 AA7 THR A 177 LEU A 181 5 5 HELIX 8 AA8 SER A 182 ARG A 187 1 6 HELIX 9 AA9 LYS A 193 GLY A 210 1 18 HELIX 10 AB1 ASP A 218 GLY A 229 1 12 HELIX 11 AB2 PRO A 236 VAL A 241 5 6 HELIX 12 AB3 THR A 242 LEU A 253 1 12 HELIX 13 AB4 THR A 262 LEU A 267 1 6 HELIX 14 AB5 HIS A 269 GLN A 274 1 6 HELIX 15 AB6 GLN A 274 ALA A 279 1 6 HELIX 16 AB7 ARG A 284 LEU A 300 1 17 HELIX 17 AB8 THR B 8 GLU B 13 1 6 HELIX 18 AB9 LYS B 48 LEU B 50 5 3 HELIX 19 AC1 SER B 51 LEU B 68 1 18 HELIX 20 AC2 GLU B 97 VAL B 103 1 7 HELIX 21 AC3 SER B 109 ASN B 130 1 22 HELIX 22 AC4 LYS B 138 GLU B 140 5 3 HELIX 23 AC5 THR B 177 LEU B 181 5 5 HELIX 24 AC6 SER B 182 ARG B 187 1 6 HELIX 25 AC7 LYS B 193 GLY B 210 1 18 HELIX 26 AC8 ASP B 218 ALA B 228 1 11 HELIX 27 AC9 PRO B 236 VAL B 241 5 6 HELIX 28 AD1 THR B 242 LEU B 253 1 12 HELIX 29 AD2 THR B 262 LEU B 267 1 6 HELIX 30 AD3 HIS B 269 GLN B 274 1 6 HELIX 31 AD4 GLN B 274 ALA B 279 1 6 HELIX 32 AD5 ARG B 284 LYS B 299 1 16 SHEET 1 AA1 5 TYR A 14 LYS A 22 0 SHEET 2 AA1 5 VAL A 27 LYS A 33 -1 O ARG A 30 N PHE A 17 SHEET 3 AA1 5 GLU A 39 ASN A 46 -1 O ILE A 44 N VAL A 27 SHEET 4 AA1 5 PHE A 85 ASP A 91 -1 O LEU A 88 N LYS A 43 SHEET 5 AA1 5 LEU A 76 GLU A 82 -1 N HIS A 77 O VAL A 89 SHEET 1 AA2 2 ILE A 132 VAL A 133 0 SHEET 2 AA2 2 ILE A 162 GLU A 163 -1 O ILE A 162 N VAL A 133 SHEET 1 AA3 2 LEU A 142 LEU A 144 0 SHEET 2 AA3 2 VAL A 153 LEU A 155 -1 O LYS A 154 N LEU A 143 SHEET 1 AA4 5 TYR B 14 LYS B 22 0 SHEET 2 AA4 5 VAL B 27 LYS B 33 -1 O ARG B 30 N PHE B 17 SHEET 3 AA4 5 GLU B 39 ASN B 46 -1 O ILE B 44 N VAL B 27 SHEET 4 AA4 5 PHE B 85 ASP B 91 -1 O PHE B 90 N ALA B 41 SHEET 5 AA4 5 LEU B 76 SER B 81 -1 N HIS B 77 O VAL B 89 SHEET 1 AA5 2 ILE B 132 VAL B 133 0 SHEET 2 AA5 2 ILE B 162 GLU B 163 -1 O ILE B 162 N VAL B 133 SHEET 1 AA6 2 LEU B 142 LEU B 144 0 SHEET 2 AA6 2 VAL B 153 LEU B 155 -1 O LYS B 154 N LEU B 143 CISPEP 1 SER A 235 PRO A 236 0 2.82 CISPEP 2 SER B 235 PRO B 236 0 4.17 SITE 1 AC1 11 LEU A 20 VAL A 28 ALA A 41 VAL A 74 SITE 2 AC1 11 PHE A 90 ASP A 91 VAL A 93 GLU A 140 SITE 3 AC1 11 ASN A 141 LEU A 143 ASP A 157 SITE 1 AC2 7 GLN A 118 ILE A 272 CYS A 273 GLN A 274 SITE 2 AC2 7 ARG A 275 SER A 276 HOH A 623 SITE 1 AC3 6 GLN B 118 ILE B 272 CYS B 273 GLN B 274 SITE 2 AC3 6 ARG B 275 SER B 276 SITE 1 AC4 13 LEU B 20 GLY B 21 VAL B 28 ALA B 41 SITE 2 AC4 13 PHE B 90 ASP B 91 LEU B 92 VAL B 93 SITE 3 AC4 13 GLU B 140 ASN B 141 LEU B 143 ASP B 157 SITE 4 AC4 13 HOH B 508 CRYST1 54.149 68.110 84.825 90.00 94.56 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018468 0.000000 0.001472 0.00000 SCALE2 0.000000 0.014682 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011826 0.00000